Lenar Aimee J.
President, US Pharma
- Shares
- 36,827
- Price
- $7.03
- Value
- $258,894
BHC
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$258,894
0 buyers · 1 sellers
12-month purchases
$15,625,000
1 distinct insiders
12-month sales
$373,933
2 distinct insiders
Highlighted alerts
6
5 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BHC overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Represents shares of the Issuer's common stock, no par value, sold in the open market pursuant to a Rule 10b5-1 trading plan to fund estimated tax obligations arising from a previously vested equity award granted to the Issuer's non-employee directors.
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
Lenar Aimee J.
President, US Pharma
Carson Seana
EVP, General Counsel
Carson Seana
EVP, General Counsel
Carson Seana
EVP, General Counsel
PAULSON & CO. INC.
10% owner
Carson Seana
EVP, General Counsel
Lee Frank D.
Director
Paulson John
Director
Paulson John
Director
Paulson John
Director
Paulson John
Director
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Lenar Aimee J. President, US Pharma | Sale | 36,827 | $7.03 | $258,894 | |
| Mar 03, 2026 | Carson Seana EVP, General Counsel | Sale | 4,420 | $5.77 | $25,503 | |
| Mar 02, 2026 | Carson Seana EVP, General Counsel | Sale | 6,856 | $5.78 | $39,628 | |
| Feb 27, 2026 | Carson Seana EVP, General Counsel | Sale | 8,388 | $5.95 | $49,909 | |
| Nov 25, 2025 | PAULSON & CO. INC. 10% owner | Purchase | 2,500,000 | $6.25 | $15,625,000 | |
| Sep 08, 2025 | Carson Seana EVP, General Counsel | Sale | 13,370 | $7.31 | $97,735 | |
| Aug 21, 2025 | Lee Frank D. Director | Sale | 15,912 | $7.66 | $121,886 | |
| Aug 14, 2025 | Paulson John Director | Purchase | 34,721,118 | $9.00 | $312,490,062 | |
| Aug 13, 2025 | Paulson John Director | Purchase | 86,409 | $7.06 | $610,048 | |
| Aug 12, 2025 | Paulson John Director | Purchase | 1,156,640 | $6.88 | $7,957,683 | |
| Aug 11, 2025 | Paulson John Director | Purchase | 2,000,000 | $6.35 | $12,700,000 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.